Company profile
INmuneBIO company profile
INmune Bio is a clinical-stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells’ ability to eliminate residual disease.
Business identity
- Website
- http://www.inmunebio.com/
- Contact email
- [email protected]
- Phone number
- (858) 964 3720
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0+
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- San Diego, California, United States
- Postal code
- 92037
- Country code
- US
- Continent
- North America